BR112015024522A8 - éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir o éter de celulose esterificado - Google Patents
éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir o éter de celulose esterificado Download PDFInfo
- Publication number
- BR112015024522A8 BR112015024522A8 BR112015024522A BR112015024522A BR112015024522A8 BR 112015024522 A8 BR112015024522 A8 BR 112015024522A8 BR 112015024522 A BR112015024522 A BR 112015024522A BR 112015024522 A BR112015024522 A BR 112015024522A BR 112015024522 A8 BR112015024522 A8 BR 112015024522A8
- Authority
- BR
- Brazil
- Prior art keywords
- esterified cellulose
- cellulose ether
- chr
- composition
- dosage form
- Prior art date
Links
- 229920003086 cellulose ether Polymers 0.000 title abstract 5
- 239000002775 capsule Substances 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000007962 solid dispersion Substances 0.000 title abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B13/00—Preparation of cellulose ether-esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361822977P | 2013-05-14 | 2013-05-14 | |
| PCT/US2014/037070 WO2014186185A1 (en) | 2013-05-14 | 2014-05-07 | Cellulose ethers esterified with dicarboxylic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112015024522A2 BR112015024522A2 (cg-RX-API-DMAC7.html) | 2017-08-22 |
| BR112015024522A8 true BR112015024522A8 (pt) | 2019-12-10 |
Family
ID=50977076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015024522A BR112015024522A8 (pt) | 2013-05-14 | 2014-05-07 | éter de celulose esterificado, composição, dispersão sólida, forma de dosagem, invólucro de cápsula e processo para produzir o éter de celulose esterificado |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9890221B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2997046B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6306691B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20160006788A (cg-RX-API-DMAC7.html) |
| CN (1) | CN105164162B (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015024522A8 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014186185A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6683561B2 (ja) * | 2016-07-12 | 2020-04-22 | 信越化学工業株式会社 | 腸溶性硬カプセル用組成物及び腸溶性硬カプセルの製造方法 |
| CN112704671B (zh) * | 2020-12-28 | 2022-04-19 | 普洛药业股份有限公司 | 一种阿莫西林克拉维酸钾胶囊及其制备方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226981A (en) | 1977-09-28 | 1980-10-07 | Shin-Etsu Chemical Co., Ltd. | Ether-ester derivatives of cellulose and their applications |
| DE2917104A1 (de) | 1979-04-27 | 1980-11-06 | Hoechst Ag | Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung |
| JPS607492B2 (ja) * | 1979-04-28 | 1985-02-25 | 信越化学工業株式会社 | 腸溶性カプセル |
| US4365060A (en) | 1979-04-28 | 1982-12-21 | Shin-Etsu Chemical Co. Ltd. | Enterosoluble capsules |
| JPS5632424A (en) * | 1979-08-27 | 1981-04-01 | Shin Etsu Chem Co Ltd | Preparation of formed enteric product |
| JPS6225101A (ja) | 1985-07-24 | 1987-02-03 | Shin Etsu Chem Co Ltd | 低重合度セルロ−スエ−テルの製造方法 |
| JPS6281402A (ja) | 1985-10-07 | 1987-04-14 | Shin Etsu Chem Co Ltd | セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法 |
| DE3620991A1 (de) | 1986-06-23 | 1988-01-14 | Henkel Kgaa | Wasserloesliche alkenyl- oder alkylbernsteinsaeureester enthaltende celluloseether |
| DE4404840A1 (de) * | 1994-02-16 | 1995-08-17 | Wolff Walsrode Ag | Thermoplastische biologisch abbaubare Polysaccharidderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| DE19529409A1 (de) | 1995-08-10 | 1997-02-13 | Wolff Walsrode Ag | Maleinsäureadditionsproduktgruppen enthaltende, thermoplastische und biologisch abbaubare Polysaccharidester/-etherester |
| EP0872233A1 (en) | 1997-04-14 | 1998-10-21 | Janssen Pharmaceutica N.V. | Antiretroviral compositions with improved bioavailability |
| US6261218B1 (en) | 1998-12-01 | 2001-07-17 | The Dow Chemical Company | Process and apparatus for making low molecular weight cellulose ethers |
| WO2000078285A1 (en) * | 1999-06-18 | 2000-12-28 | University Of Medicine And Dentistry Of New Jersey | Controlled release of therapeutics by in-situ entrapment by matrix cross-linking |
| US20020076443A1 (en) * | 2000-06-19 | 2002-06-20 | Stanley Stein | Multiple phase cross-linked compositions and uses thereof |
| DE10141680B4 (de) | 2001-08-25 | 2004-02-26 | Clariant Gmbh | Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern |
| JP2003073443A (ja) * | 2001-08-31 | 2003-03-12 | Hiroshi Takimoto | 生分解性高吸水性樹脂 |
| JP2003160694A (ja) * | 2001-11-28 | 2003-06-03 | Hiroshi Takimoto | 生分解性組成物 |
| EP1753402B1 (en) | 2004-05-28 | 2008-10-01 | Pfizer Products Incorporated | Pharmaceutical compositions with enhanced performance comprising a hpmca polymer |
| WO2009061815A1 (en) | 2007-11-09 | 2009-05-14 | Union Carbide Chemicals & Plastics Technology Llc | Method for preparing very low viscosity cellulose ether and product |
| JP2011504524A (ja) | 2007-11-09 | 2011-02-10 | ダウ グローバル テクノロジーズ インコーポレイティド | セルロースエーテルコーティング組成物および方法 |
| CN102933615B (zh) * | 2010-06-08 | 2015-08-12 | 陶氏环球技术有限责任公司 | 制备粒状可逆交联的聚合物材料的方法 |
| WO2011159626A1 (en) | 2010-06-14 | 2011-12-22 | Bend Research, Inc. | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| US9320799B2 (en) * | 2012-04-11 | 2016-04-26 | Dow Global Technologies Llc | Esterified cellulose ethers having a specific substituent distribution |
| CN102807625A (zh) * | 2012-08-23 | 2012-12-05 | 浙江中维药业有限公司 | 一种醋酸羟丙甲纤维素琥珀酸酯的制备方法 |
-
2014
- 2014-05-07 EP EP14731443.9A patent/EP2997046B1/en active Active
- 2014-05-07 KR KR1020157035306A patent/KR20160006788A/ko not_active Ceased
- 2014-05-07 WO PCT/US2014/037070 patent/WO2014186185A1/en not_active Ceased
- 2014-05-07 BR BR112015024522A patent/BR112015024522A8/pt not_active Application Discontinuation
- 2014-05-07 US US14/777,838 patent/US9890221B2/en not_active Expired - Fee Related
- 2014-05-07 JP JP2016513984A patent/JP6306691B2/ja not_active Expired - Fee Related
- 2014-05-07 CN CN201480024334.0A patent/CN105164162B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015024522A2 (cg-RX-API-DMAC7.html) | 2017-08-22 |
| KR20160006788A (ko) | 2016-01-19 |
| EP2997046B1 (en) | 2019-09-25 |
| US9890221B2 (en) | 2018-02-13 |
| CN105164162A (zh) | 2015-12-16 |
| CN105164162B (zh) | 2017-11-28 |
| JP6306691B2 (ja) | 2018-04-04 |
| US20160289344A1 (en) | 2016-10-06 |
| JP2016519198A (ja) | 2016-06-30 |
| WO2014186185A1 (en) | 2014-11-20 |
| EP2997046A1 (en) | 2016-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019007575A2 (pt) | sistema de mapeamento e orientação terrestre | |
| AR104174A1 (es) | Oxadiazoles sustituidos con deuterio | |
| BR112015028605A8 (pt) | uso de uma composição e uso de um imunossupressor e uma composição | |
| EA201790693A1 (ru) | Коррекция фигуры | |
| BR112017003049A2 (pt) | descoberta de conteúdo distante | |
| BR112015023142A8 (pt) | moduladores do p2x7,seu uso, processo de preparação e composição farmacêutico que os compreende | |
| MX374118B (es) | Minerales que contienen carbonato de calcio de superficie modificada y su uso. | |
| BR122019009442B8 (pt) | aparelho para produzir uma estrutura que inclui uma pluralidade de fibras | |
| CL2015003290A1 (es) | Nuevos agonistas del receptor de somatostatina subtipo 4 (sstr4). | |
| CL2018000107A1 (es) | Moléculas de anticuerpo que se unen a cd79 | |
| MX394081B (es) | Método para preparar un producto lácteo que tiene un contenido estable de galactooligosacárido (s). | |
| BR112017019587A2 (pt) | material que compreende carbonato de cálcio revestido superficialmente e compósito, processo para preparação do material que compreende carbonato de cálcio revestido superficialmente, para purificação de água e/ou desidratação de lamas e/ou sedimento em suspensão, e, uso de um material que compreende carbonato de cálcio revestido superficialmente. | |
| BR112017014049A2 (pt) | método para reduzir a perda de circulação em uma formação subterrânea, fluido de tratamento e sistema para obstrução de uma zona de perda de circulação | |
| SG10201805024YA (en) | Methods useful in the synthesis of halichondrin b analogs | |
| BR112016024554A2 (pt) | ?conjunto de cabeça de trépano para recuperação de testemunhos? | |
| MX2019002123A (es) | Metodo para producir estructuras absorbentes con alta resistencia a la humedad, absorbencia, y suavidad. | |
| BR112016007375A2 (pt) | conjuntos de procedimentos para habilitar comunicações sem fio com o uso de estruturas de subquadro que tenham diferentes durações de subquadro | |
| MX370547B (es) | Sistema de inyeccion de una suspension de carbonato de calcio (caco3) micronizada para la remineralizacion del agua desalinizada y dulce. | |
| BR112015022828A2 (pt) | remoção de cloro e/ou cloramina de soluções aquosas | |
| MX362383B (es) | Moduladores de acido oxabiciclo[2.2.2] gpr120. | |
| UY36444A (es) | Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método | |
| BR112017028349A2 (pt) | barreiras ao oxigênio à base de fibras de celulose modificadas, uso e métodos de formação das mesmas | |
| BR112014002706A2 (pt) | métodos para produção no local de cloramina e uso da mesma | |
| BR112013011428A2 (pt) | composição para modificar quimicamente a região interna de um fio de cabelo | |
| BR112018006100A2 (pt) | método e aparelho para deduplicação de linha de cache por meio de correspondência de dados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |